Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Expert Opinion on Therapeutic Patents|May 16, 2012
Sodium glucose co-transporter 2 (SGLT2) inhibitors: novel antidiabetic agentsWilliam N WashburnExpert Opinion on Therapeutic Patents|October 27, 2009
Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agentsWilliam N WashburnExpert Opinion on Investigational Drugs|March 5, 2013
Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitusWilliam N Washburn, Simon M PoucherOptics Express|May 28, 2009
Collinear optical coherence and confocal fluorescence microscopies for tissue engineeringJ Dunkers, M Cicerone, N WashburnNeuromodulation : Journal of the International Neuromodulation Society|October 14, 2011
Successful treatment of charcot-marie-tooth chronic pain with spinal cord stimulation: a case studyIoannis M Skaribas, Stephanie N WashburnThe Journal of Biological Chemistry|March 15, 1991
Suicide-inhibitory bifunctionally linked substrates (SIBLINKS) as phospholipase A2 inhibitors. Mechanistic implicationsW N Washburn, E A DennisThe Behavioral and Brain Sciences|January 21, 2016
A checklist to facilitate objective hypothesis testing in social psychology researchAnthony N Washburn, G Scott Morgan, Linda J SkitkaPlos One|June 22, 2018
Moral and religious convictions: Are they the same or different things?Linda J Skitka, Brittany E Hanson, Anthony N Washburn, et al.Behavioral Neuroscience|August 23, 2003
GABA(A) receptor activation is involved in noncontingent shock inhibition of instrumental conditioning in spinal ratsAdam R Ferguson, Stephanie N Washburn, Eric D Crown, et al.Neurobiology of Learning and Memory|November 7, 2007
Opioid regulation of spinal cord plasticity: evidence the kappa-2 opioid receptor agonist GR89696 inhibits learning within the rat spinal cordStephanie N Washburn, Marissa L Maultsby, Denise A Puga, et al.Pageof 4